Ajinomoto Co Inc buy gerihouse
Summary
This prediction ended on 23.01.15 with a price of €17.39. The BUY prediction by gerihouse finished with a performance of 10.08%. gerihouse has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ajinomoto Co Inc | 5.920% | 5.920% | 5.274% | - |
| iShares Core DAX® | 2.594% | -1.158% | 14.782% | 16.813% |
| iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% | 44.227% |
| iShares Nikkei 225® | 0.687% | -8.354% | 18.454% | 1.361% |
| iShares S&P 500 | 2.209% | -0.942% | 31.361% | 42.812% |
Comments by gerihouse for this prediction
In the thread Ajinomoto Co Inc diskutieren
No. 1 supplier
Ajinomoto steigt und steigt, der Yen hilft!
Ajinomoto Genexine Co. has started full-scale operations of a new plant in Incheon, South Korea, for cell culture media used in biopharmaceutical manufacturing, Ajinomoto Co. said Oct. 20.
With the launch of the plant, the subsidiary, Ajinomoto Genexine, is seeking to build a global supply structure for the cell culture media market centered on the Asian region, which is expected to grow to about 200 billion yen ($1.88 billion) by 2020.
Biopharmaceuticals, which offer new treatment methods for previously intractable diseases, are manufactured by cultivating mammalian cells. The global market is rapidly expanding, mainly for therapeutic antibodies such as anticancer agents and rheumatoid arthritis treatments, and is expected to exceed 20 trillion yen by 2020.
The use of biopharmaceuticals in emerging countries, and the introduction of their generic counterparts (known as biosimilars) in Japan, Europe and elsewhere are leading to further expansion of the market.
With active investment in the development of biosimilars in South Korea, where the new plant is located, a rapid increase is expected in demand for cell culture media used in their manufacture.
Ajinomoto is the world’s No. 1 supplier of amino acids for pharmaceuticals and foods.
The cell culture media business is a pillar of its amino acid operations. Amino acids are an essential component of cell culture media. Ajinomoto Genexine uses the Ajinomoto Group's advanced amino acid technology to manufacture high-quality cell culture media optimized to meet customers' needs.
Cell culture media made by Ajinomoto Genexine are sold globally via other Ajinomoto Group companies. Ajinomoto Genexine will conduct sales directly within South Korea
